Reinaldo Acevedo - Search Results

Year	Number of Results
2004	1
2006	6
2008	1
2009	4
2011	1
2012	2
2013	3
2014	1
2016	1
2017	1
2018	1
2019	4
2022	2
2024	0

1

The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection.

Farouq MAH, Acevedo R, Ferro VA, Mulheran PA, Al Qaraghuli MM. Farouq MAH, et al. Among authors: acevedo r. Int J Mol Sci. 2022 May 28;23(11):6078. doi: 10.3390/ijms23116078. Int J Mol Sci. 2022. PMID: 35682757 Free PMC article. Review.

2

Mucosal and systemic immune responses following mucosal immunisation of tetanus toxoid entrapped in lipid nanoparticles prepared by microwave reactor.

Gebril A, Obeid MA, Bennett EM, Pujol A, Chovel ML, Mahy T, Acevedo R, Ferro VA. Gebril A, et al. Among authors: acevedo r. Eur J Pharm Biopharm. 2022 Feb;171:11-18. doi: 10.1016/j.ejpb.2021.12.014. Epub 2022 Jan 4. Eur J Pharm Biopharm. 2022. PMID: 34990784 Free article.

3

Repeat-Dose Toxicity Study Using the AFPL1-Conjugate Nicotine Vaccine in Male Sprague Dawley Rats.

Oliva R, Fraleigh NL, Lewicky JD, Fariñas M, Hernández T, Martel AL, Navarro I, Dagmar GR, Acevedo R, Le HT. Oliva R, et al. Among authors: acevedo r. Pharmaceutics. 2019 Nov 23;11(12):626. doi: 10.3390/pharmaceutics11120626. Pharmaceutics. 2019. PMID: 31771151 Free PMC article.

4

Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes.

Fraleigh NL, Oliva R, Lewicky JD, Martel AL, Acevedo R, Dagmar GR, Le HT. Fraleigh NL, et al. Among authors: acevedo r. PLoS One. 2019 Aug 23;14(8):e0221708. doi: 10.1371/journal.pone.0221708. eCollection 2019. PLoS One. 2019. PMID: 31442285 Free PMC article.

5

Monoclonal Antibodies Against the Capsular Polysaccharides A, C, Y, W, and X of Neisseria meningitidis: A Platform for the Quality Control of Meningococcal Vaccines.

González E, Reyes F, Otero O, Camacho F, Cuello M, Ramírez F, Acevedo R. González E, et al. Among authors: acevedo r. Methods Mol Biol. 2019;1969:181-203. doi: 10.1007/978-1-4939-9202-7_13. Methods Mol Biol. 2019. PMID: 30877678

6

The Global Meningococcal Initiative meeting on prevention of meningococcal disease worldwide: Epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations.

Acevedo R, Bai X, Borrow R, Caugant DA, Carlos J, Ceyhan M, Christensen H, Climent Y, De Wals P, Dinleyici EC, Echaniz-Aviles G, Hakawi A, Kamiya H, Karachaliou A, Lucidarme J, Meiring S, Mironov K, Sáfadi MAP, Shao Z, Smith V, Steffen R, Stenmark B, Taha MK, Trotter C, Vázquez JA, Zhu B. Acevedo R, et al. Expert Rev Vaccines. 2019 Jan;18(1):15-30. doi: 10.1080/14760584.2019.1557520. Epub 2018 Dec 27. Expert Rev Vaccines. 2019. PMID: 30526162 Review.

7

Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa.

Acevedo R, Zayas C, Norheim G, Fernández S, Cedré B, Aranguren Y, Cuello M, Rodriguez Y, González H, Mandiarote A, Pérez M, Hernández M, Hernández-Cedeño M, González D, Brorson SH, Rosenqvist E, Naess L, Tunheim G, Cardoso D, García L. Acevedo R, et al. Pharmacol Res. 2017 Jul;121:194-201. doi: 10.1016/j.phrs.2017.04.030. Epub 2017 May 8. Pharmacol Res. 2017. PMID: 28495657

8

Evaluating the immunogenicity of an intranasal vaccine against nicotine in mice using the Adjuvant Finlay Proteoliposome (AFPL1).

Fraleigh NL, Boudreau J, Bhardwaj N, Eng NF, Murad Y, Lafrenie R, Acevedo R, Oliva R, Diaz-Mitoma F, Le HT. Fraleigh NL, et al. Among authors: acevedo r. Heliyon. 2016 Aug 26;2(8):e00147. doi: 10.1016/j.heliyon.2016.e00147. eCollection 2016 Aug. Heliyon. 2016. PMID: 27622215 Free PMC article.

9

Bacterial outer membrane vesicles and vaccine applications.

Acevedo R, Fernández S, Zayas C, Acosta A, Sarmiento ME, Ferro VA, Rosenqvist E, Campa C, Cardoso D, Garcia L, Perez JL. Acevedo R, et al. Front Immunol. 2014 Mar 24;5:121. doi: 10.3389/fimmu.2014.00121. eCollection 2014. Front Immunol. 2014. PMID: 24715891 Free PMC article. Review.

10

Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B.

Zayas C, González D, Acevedo R, del Campo J, Lastre M, González E, Romeu B, Cuello M, Balboa J, Cabrera O, Guilherme L, Pérez O. Zayas C, et al. Among authors: acevedo r. BMC Immunol. 2013;14 Suppl 1(Suppl 1):S4. doi: 10.1186/1471-2172-14-S1-S4. Epub 2013 Feb 25. BMC Immunol. 2013. PMID: 23458578 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year